Investments to the tune of 2 trillion yen ($17.54 billion) in development of alternative energies such as renewables and hydrogen will be made by Japanese company Mitsubishi Corp by 2030, the company said on Monday, and added that this will… Read More ›
The Indian pharma company Bharat Biotech got a further set back on Monday with respect to its hopes of being granted an emergency-use listing by the World Health Organization for the Covid-19 vaccine developed by it called Covxin as the… Read More ›
manageria.biz 